- Display 30 Products per page
Published: November 1, 2009 | Price: $3,500.00 – $7,000.00
The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets. Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of...Published: November 1, 2009 | Price: $3,995.00 – $7,990.00
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot...Published: October 1, 2009 | Price: $3,500.00 – $7,000.00
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to them. This Kalorama Information The World Market for Anti-Infectives considers the anti-infective drug market as it faces challenges with resistance and generic competition. The report focuses on three key segments of...Published: October 1, 2009 | Price: $995.00 – $1,990.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...Published: October 1, 2009 | Price: $995.00 – $1,990.00
At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. health care system, in response to a variety of factors including continually rising costs of care and declining quality of life. A Comprehensive Look at the 'Wellness' Industry Utilization of wellness programs in the United States has experienced strong recent growth this is expected to continue...Published: September 1, 2009 | Price: $2,995.00 – $5,990.00
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports...Published: September 1, 2009 | Price: $1,995.00 – $3,990.00
The recession will have an impact on any elective medical procedure, and dental implants (and the resulting bone grafts) are no exception. Since the last edition of Kalorama Information's Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, economic conditions have changed in US and world markets, but the industry has also changed: mergers, new products, an increase in computer design and trained dentists are driving growth, as is reimbursement. This study, now in its third edition, provides a...Published: August 1, 2009 | Price: $1,995.00 – $7,000.00
The healthcare information technology (HIT) market was in a growth trend prior to the recent recession. While economic times have tightened budgets some, there is still opportunities for companies in this market. In this report, Kalorama takes a comprehensive look at the demand for IT products in the healthcare market - with a focus on computer systems for hospitals, nursing homes, physician offices and other healthcare entities. Kalorama has interviewed experts in the HIT industry and presents the latest findings...Published: August 1, 2009 | Price: $3,800.00 – $7,600.00
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or...Published: August 1, 2009 | Price: $3,500.00 – $7,000.00
This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI. the report includes the following as part of its market coverage: Current Market Size and Forecast for MRI Systems Market Size and Forecasts for MRI Procedures Installed Base of MRI Systems (Open, Closed, Low to Mid Field, High...Published: July 1, 2009 | Price: $995.00 – $1,900.00
As Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies The report is written by Kalorama's lead diagnostic expert, Shara Rosen, R.T. M.B.A., author of six best-selling editions of the industry's leading market research report...Published: July 1, 2009 | Price: $995.00 – $1,900.00
The information represented in this report is a comprehensive analysis of the eye care market globally with a special focus on the United States and selected international sectors. The year ending December 31, 2008 was used as the base year with forecasts to the year 2013. Market statistics are given in U.S. dollars and in units [where appropriate]. Basis for the market analysis consists of key data, statistics; references, and information from a large data base of primary and secondary...Published: June 1, 2009 | Price: $3,995.00 – $7,990.00
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used in humans to previous various types of disease. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are...Published: June 1, 2009 | Price: $3,500.00 – $7,000.00
New technologies are transforming patient monitoring and Kalorama Information has reported on these developments last year. This report, High-Tech Patient Monitoring market updates revenues and segment breakdowns to reflect changes in the market, particularly the remote monitoring and the enhanced role of applications to transfer patient data to EMR systems. Advances in remote patient monitoring include new peripherals, real-time audio and video for “face-to-face” interaction between clinicians and patients, wireless communication, systems that “sort” the vast amount of data collected...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: May 1, 2009 | Price: $995.00 – $7,990.00
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The...Published: May 1, 2009 | Price: $995.00 – $7,000.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of this decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's...Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: May 1, 2009 | Price: $1,500.00 – $9,000.00
Kalorama Information's 300 page Worldwide Wound Care: Total Market Coverage report represents the full contents of the Kalorama three-volume 2009 wound care series. The reports are joined in one volume to offer a better value to the customer that wants total market coverage. Kalorama's approach differs from other published reports in that we segment the world wound care market by application: skin ulcers, burns and surgical/trauma wounds. Wound care is a vast market and this approach ensures that customers can...Published: May 1, 2009 | Price: $2,995.00 – $5,990.00
There are millions of surgical procedures performed annually worldwide and the market for wound care products and techniques is significant. Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area and thus an important market. Kalorama Information's Wound Care Series offers one of the most complete market round-ups published recently, featuring the following: This is the only recently published market research study to provide Wound Care Revenues by Condition/Treatment. This report,...Published: May 1, 2009 | Price: $2,995.00 – $7,990.00
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report, Cell Culture represents the second time that Kalorama...Published: May 1, 2009 | Price: $995.00 – $7,000.00
The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades. This report, World Veterinary Health Products, takes a look at veterinary health products for both companion (pet) animals, and production animals (livestock and poultry) and the opportunity for existing players and...Published: April 1, 2009 | Price: $995.00 – $2,590.00
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including: Market Size and Forecast...Published: April 1, 2009 | Price: $995.00 – $7,000.00
Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and...Published: April 1, 2009 | Price: $500.00 – $3,990.00
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible...Published: April 1, 2009 | Price: $2,995.00 – $5,990.00
Wound care is a constantly changing market. New wound care products and devices are entering the market with quickly to treat the most painful and critical of injuries, all striving for the best clinical outcomes. Kalorama's Wound Care Markets, 4th Edition, Vol. II: Burns represents the fourth time that Kalorama has rexamined this aspect of the wound care market, and the study analyzes burn treatment in wound care in the following product segments and subsegments: : Anti-infectives Burn Injury Management,...Published: April 1, 2009 | Price: $995.00 – $7,000.00
The dialysis industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - only 1.8 million dialysis patients form its entire...Published: April 1, 2009 | Price: $1,500.00 – $9,990.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...Published: March 1, 2009 | Price: $995.00 – $5,990.00
Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Kalorama's Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers. represents the fourth time that Kalorama has rexamined this aspect of the wound care market, and the study analyzes the market using the following product...Published: March 1, 2009 | Price: $1,995.00 – $7,000.00
The appearance of in-store health clinics is a significant trend for pharmaceutical and POC diagnostic market watchers, as well as for those in retail. When last Kalorama published the first syndicated market research study on the emerging trend of in-store clinics in 2007, retail clinics were a novel trend. Now, with a few years of activity, they are established in food, drug, mass merchandizing and other stores, with both successes and failures. There is growth in some projects, scalebacks in...